Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any age-related macular degeneration in which the cause of the disease is a mutation in the RAX2 gene.
Features include: Macular degeneration.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 1 | Macular degeneration |
RAX2 function has not been fully characterized.
Age related macular degeneration 6 is associated with mutations in the RAX2 gene on chromosome 19.
Genetic testing for RAX2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for age related macular degeneration 6 has been reported in the published literature.
No clinical trials have been registered for age related macular degeneration 6.
287 publications have been identified in PubMed for age related macular degeneration 6. Kisho has analyzed 187 by research type. Research spans Epidemiology / Natural History (33%), Basic Science / Preclinical (21%), and Clinical Trial Publication (20%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 61 | 33% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 6:52 AM UTC
Online Mendelian Inheritance in Man
Common questions about age related macular degeneration 6
Laboratory research |
39 |
21% |
Clinical study results | 38 | 20% |
Research summaries | 26 | 14% |
Testing and diagnosis research | 13 | 7% |
Patient case studies | 5 | 3% |
New treatment approaches | 5 | 3% |
Yang CC (2026). [PMID: 41276957](https://pubmed.ncbi.nlm.nih.gov/41276957/). *J Chin Med Assoc*. [Clinical Trial Publication]
Pitcher JD 3rd (2026). [PMID: 41712218](https://pubmed.ncbi.nlm.nih.gov/41712218/). *JAMA Ophthalmol*. [Clinical Trial Publication]
Korobelnik JF (2026). [PMID: 40876598](https://pubmed.ncbi.nlm.nih.gov/40876598/). *Ophthalmology*. [Clinical Trial Publication]
Ansari G (2026). [PMID: 42212881](https://pubmed.ncbi.nlm.nih.gov/42212881/). *Invest Ophthalmol Vis Sci*. [Basic Science / Preclinical]
Vahldiek A (2026). [PMID: 41247474](https://pubmed.ncbi.nlm.nih.gov/41247474/). *Graefes Arch Clin Exp Ophthalmol*. [Diagnostic / Biomarker]
Zhou B (2026). [PMID: 41809655](https://pubmed.ncbi.nlm.nih.gov/41809655/). *Exp Biol Med (Maywood)*. [Review / Meta-Analysis]
Tao L (2026). [PMID: 41390091](https://pubmed.ncbi.nlm.nih.gov/41390091/). *Life Sci*. [Basic Science / Preclinical]
Sun D (2026). [PMID: 41475545](https://pubmed.ncbi.nlm.nih.gov/41475545/). *Ophthalmology*. [Epidemiology / Natural History]
Jaffe GJ (2026). [PMID: 41791029](https://pubmed.ncbi.nlm.nih.gov/41791029/). *Retina*. [Clinical Trial Publication]
Myers WK (2026). [PMID: 41453515](https://pubmed.ncbi.nlm.nih.gov/41453515/). *Ophthalmol Retina*. [Epidemiology / Natural History]